Publications by authors named "Matthew Onorato"

Claim this Profile
S
Single and Multiple Doses of Seladelpar Decrease Diurnal Markers of Bile Acid Synthesis in Mice.
Edward E Cable, Jeffrey W Stebbins, Jeff D Johnson, Yun-Jung Choi, Jiangao Song, Matthew Onorato

PPAR Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Andrew W Lee, Ken Liu, Edouard Lhomme, Julie Blie, John McCullough, Matthew T Onorato

Clin Infect Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Pandemic Vaccines: ERVEBO Case Study.
Jayanthi Wolf, Risat Jannat, Sheri Dubey, Sean Troth, Matthew T Onorato

Vaccines (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction.
Benedetto Vitiello, Graham Emslie, Gregory Clarke, Karen Dineen Wagner, Joan R Asarnow, Matthew Onorato

J Clin Psychiatry· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults.
Scott A Halperin, Rituparna Das, Matthew T Onorato, Kenneth Liu, Jason Martin

J Infect Dis· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults.
Scott A Halperin, Jose R Arribas, Richard Rupp, Charles P Andrews, Laurence Chu, Matthew T Onorato

J Infect Dis· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staphylococcus aureus Infections After Elective Cardiothoracic Surgery: Observations From an International Randomized Placebo-Controlled Trial of an Investigational S aureus Vaccine.
Keith B Allen, Vance G Fowler, James S Gammie, Jonathan S Hartzel, Matthew T Onorato

Open Forum Infect Dis· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of pain-predominant functional gastrointestinal disorders and somatic symptoms in patients with anxiety or depressive disorders.
Desale Yacob, Carlo Di Lorenzo, Jeffrey A Bridge, Patricia Fine Rosenstein, Matthew Onorato

J Pediatr· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.
Vance G Fowler, Keith B Allen, Edson D Moreira, Moustafa Moustafa, Frank Isgro, Matthew T Onorato

JAMA· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): results of two Phase I studies.
Clayton D Harro, Robert F Betts, Jonathan S Hartzel, Matthew T Onorato, Joy Lipka

Vaccine· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.
Benedetto Vitiello, Graham Emslie, Gregory Clarke, Karen Dineen Wagner, Joan R Asarnow, Matthew Onorato

J Clin Psychiatry· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings.
Frances L Lynch, John F Dickerson, Greg Clarke, Benedetto Vitiello, Giovanna Porta, Matthew Onorato

Arch Gen Psychiatry· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans.
Clayton Harro, Robert Betts, Walter Orenstein, Eun-Jeong Kwak, Howard E Greenberg, Matthew T Onorato

Clin Vaccine Immunol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pentavalent rotavirus vaccine in developing countries: safety and health care resource utilization.
Celia D C Christie, Newton D Duncan, Kirk A Thame, Matthew T Onorato, Hyacinth D Smith

Pediatrics· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.
Graham J Emslie, Taryn Mayes, Giovanna Porta, Benedetto Vitiello, Greg Clarke, Matthew Onorato

Am J Psychiatry· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substance use and the treatment of resistant depression in adolescents.
Benjamin I Goldstein, Wael Shamseddeen, Anthony Spirito, Graham Emslie, Greg Clarke, Matthew Onorato

J Am Acad Child Adolesc Psychiatry· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.
David Brent, Graham Emslie, Greg Clarke, Karen Dineen Wagner, Joan Rosenbaum Asarnow, Matthew Onorato

JAMA· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
Timo Vesikari, David O Matson, Penelope Dennehy, Pierre Van Damme, Mathuram Santosham, Matthew T Onorato

N Engl J Med· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis